Non-Small Cell Lung Cancer (NSCLC) Latest Advances
Find the Latest Research About Non-Small Cell Lung Cancer (NSCLC)
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 103790 publications
Immunotherapy "stop and go" and early discontinuation: A viable option in limited resources setting.
Immunotherapy "stop and go" and early discontinuation: A viable option in limited resources setting.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: April 15, 2026
Advances in Lactate Metabolic Reprogramming in Non-small Cell Lung Cancer
Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer
Published: April 14, 2026
Impact of HIF-1α-expressing Cellular Subpopulations on Lymph Node Metastasis and Postoperative Recurrence in Non-small Cell Lung Cancer
Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer
Published: April 14, 2026
Huangqi Guizhi Wuwu Decoction in the Treatment of Pemetrexed Intrathecal Chemotherapy-induced Neurotoxicity in NSCLC Patients with Leptomeningeal Metastases: A Randomized Controlled Trial
Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer
Published: April 14, 2026
RETRACTION: Kinesin Family Member 2A High Expression Correlates With Advanced Tumor Stages and Worse Prognosis in Non-Small Cell Lung Cancer Patients.
Journal: Journal of clinical laboratory analysis
Published: April 13, 2026
RETRACTION: Polo-Like Kinase 4 Correlates With Greater Tumor Size, Lymph Node Metastasis, and Confers Poor Survival in Non-Small Cell Lung Cancer.
Journal: Journal of clinical laboratory analysis
Published: April 13, 2026
RETRACTION: AKIP1 Expression in Tumor Tissue as a New Biomarker for Disease Monitoring and Prognosis in Non-Small Cell Lung Cancer: Results of a Retrospective Study.
Journal: Journal of clinical laboratory analysis
Published: April 13, 2026
Cost comparison of osimertinib plus platinum-pemetrexed versus amivantamab plus lazertinib for the first-line treatment of patients with locally advanced or metastatic epidermal growth factor receptor-mutated non-small cell lung cancer.
Journal: Journal of medical economics
Published: April 13, 2026
NGS-Based Mutation Profiling and PD-L1 Expression in NSCLC Patients: A Single-Centre Prospective Analysis.
Journal: Turk patoloji dergisi
Published: April 13, 2026
RETRACTION: Circular RNA SMARCA5 May Serve as a Tumor Suppressor in Non-Small Cell Lung Cancer.
Journal: Journal of clinical laboratory analysis
Published: April 13, 2026
RETRACTION: Potentiality of Forkhead Box Q1 as a Biomarker for Monitoring Tumor Features and Predicting Prognosis in Non-Small Cell Lung Cancer.
Journal: Journal of clinical laboratory analysis
Published: April 13, 2026
Anemoside B4 inhibits non-small cell lung cancer metastasis by modulating epithelial-mesenchymal transition mediated by the MAPK and Keap1/Nrf2 signaling pathways
Journal: Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences
Published: April 13, 2026
Last Updated: 04/28/2026